Medigen Vaccines SARS-CoV-2 qPCR Kit obtained CE Marking and Taiwan MOHW’s approval

On Apr. 30, 2020, Medigen Vaccine Biologics (MVC) announced its SARS-CoV-2 qPCR Kit complied with EU CE requirements, completed the EU declaration of conformity and obtained CE marking (IVD) on Apr. 24, 2020. In addition, MVC applied for specific medical devicesﾒ manufacturing in Taiwan.

Tags:

, ,

Source: Medigen Vaccine Biologics
Credit:

Visit News/History Source
LifeScienceHistory.com offers three advertising package options. Each package lnclude at least two digital images for multiple page placements and maximum exposure! Rates range from just $300 to $500 per month.